Sale!

MYH9 Gene Deafness Autosomal Dominant Type 17 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MYH9 Gene Deafness Autosomal Dominant Type 17 Genetic Test is a specialized diagnostic tool designed to identify mutations in the MYH9 gene, which are linked to a specific form of hearing loss known as Autosomal Dominant Nonsyndromic Deafness Type 17 (DFNA17). This condition is characterized by its inheritance pattern, where only one copy of the mutated gene, inherited from an affected parent, is sufficient to cause the disorder. The MYH9 gene plays a crucial role in the development and function of the inner ear structures, which are essential for normal hearing.

Conducted at DNA Labs UAE, this genetic test involves analyzing the patient’s DNA, extracted from a blood sample, to search for mutations in the MYH9 gene. The process is highly sophisticated and requires advanced laboratory techniques to accurately identify the genetic alteration responsible for the hearing impairment.

The cost of the MYH9 Gene Deafness Autosomal Dominant Type 17 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the intricate nature of the testing process and the specialized expertise required to interpret the results. Patients undergoing this test can expect a comprehensive analysis that will not only aid in confirming a diagnosis of DFNA17 but also provide essential information for family planning and management of the condition. The test is a critical step for affected families in understanding their genetic makeup and assessing the risk of passing the condition on to future generations.

Description

MYH9 Gene Deafness autosomal dominant type 17 Genetic Test

Components: MYH9 Gene Deafness autosomal dominant type 17 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB3

Test Details: The MYH9 gene is associated with several genetic disorders, including MYH9-related disorders, which can lead to various health conditions such as deafness, kidney problems, and bleeding disorders. Deafness, autosomal dominant type 17 (DFNA17) is a specific type of hearing loss caused by mutations in the MYH9 gene. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify any mutations or variations in the DNA sequence. This type of testing can help diagnose genetic disorders, including DFNA17. During the NGS genetic test for DFNA17, a sample of DNA is collected, typically through a blood or saliva sample. The DNA is then sequenced using advanced technology, which allows for the identification of specific mutations or variations in the MYH9 gene. The results of the test can help determine if an individual has DFNA17 or is a carrier of the condition. It is important to consult with a healthcare professional or genetic counselor before undergoing any genetic testing. They can provide guidance on the appropriateness of the test, explain the potential benefits and limitations, and help interpret the results.

Test Name	MYH9 Gene Deafness autosomal dominant type 17 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Ear Nose Throat Disorders
Doctor	ENT Doctor
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB3
Test Details	The MYH9 gene is associated with several genetic disorders, including MYH9-related disorders, which can lead to various health conditions such as deafness, kidney problems, and bleeding disorders. Deafness, autosomal dominant type 17 (DFNA17) is a specific type of hearing loss caused by mutations in the MYH9 gene. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify any mutations or variations in the DNA sequence. This type of testing can help diagnose genetic disorders, including DFNA17. During the NGS genetic test for DFNA17, a sample of DNA is collected, typically through a blood or saliva sample. The DNA is then sequenced using advanced technology, which allows for the identification of specific mutations or variations in the MYH9 gene. The results of the test can help determine if an individual has DFNA17 or is a carrier of the condition. It is important to consult with a healthcare professional or genetic counselor before undergoing any genetic testing. They can provide guidance on the appropriateness of the test, explain the potential benefits and limitations, and help interpret the results.